Detalles de la búsqueda
1.
Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States.
Oncologist
; 27(9): 790-798, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781589
2.
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry.
Breast Cancer Res Treat
; 188(1): 179-190, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641083
3.
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
Br J Cancer
; 122(3): 340-347, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31761899
4.
Real-World Treatment Patterns and Progression-Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non-Small Cell Lung Cancer.
Oncologist
; 25(10): 867-877, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32490560
5.
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.
Oncologist
; 25(2): e214-e222, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043771
6.
Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial.
Breast Cancer Res
; 21(1): 32, 2019 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30813966
7.
The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung Cancer.
Annu Rev Med
; 68: 153-168, 2017 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27618751
8.
Update on Precision Medicine in Breast Cancer.
Cancer Treat Res
; 178: 45-80, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209841
9.
Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study.
Pharmacoepidemiol Drug Saf
; 25(5): 569-77, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26748833
10.
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
BMC Cancer
; 14: 307, 2014 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24885258
11.
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
Res Sq
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38746356
12.
Non-small cell lung cancer.
J Natl Compr Canc Netw
; 10(10): 1236-71, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23054877
13.
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Mol Oncol
; 16(1): 104-115, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437759
14.
Treatment of anaplastic lymphoma kinase-positive lung adenocarcinoma with pemetrexed and carboplatin after crizotinib failure and significant liver dysfunction; a case report.
Cancer Treat Res Commun
; 26: 100291, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388727
15.
Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 22(1): 49-57, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33250347
16.
Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALKâ¯+â¯non-small cell lung cancer (ALTA-1L).
Lung Cancer
; 155: 68-77, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744781
17.
Response to Abemaciclib After 10 Lines of Therapy Including Palbociclib in Metastatic Breast Cancer: A Case Report With Literature Review.
Oncol Ther
; 8(2): 351-358, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876928
18.
Resource-Stratified Guideline-Based Cancer Care Should Be a Priority: Historical Context and Examples of Success.
Am Soc Clin Oncol Educ Book
; 40: 1-10, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223670
19.
Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors.
J Med Econ
; 23(8): 894-901, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347754
20.
Improving Quality of Cancer Care by Participating in Quality Oncology Practice Initiative Certification Program.
JCO Glob Oncol
; 6: 1087-1092, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673077